Cargando…
Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis
BACKGROUND: The prevalence of primary biliary cholangitis (PBC), which is an autoimmune liver disease, has increased over time. PBC often leads to severe consequences, such as liver failure and death. Stratification tools using biochemical liver tests are needed to assess and predict the progression...
Autores principales: | Huang, Chunyang, Han, Weijia, Wang, Chuanmin, Liu, Yanmin, Chen, Yue, Duan, Zhongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815635/ https://www.ncbi.nlm.nih.gov/pubmed/31737133 http://dx.doi.org/10.1155/2019/9121207 |
Ejemplares similares
-
Comment on “Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis”
por: Cristoferi, Laura, et al.
Publicado: (2020) -
Familial Primary Biliary Cholangitis With Different Clinical Courses Based on Anti-gp210 Antibody Positivity: A Report of Two Cases
por: Nagata, Takahiro, et al.
Publicado: (2023) -
Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report
por: Zhao, Dan-Tong, et al.
Publicado: (2020) -
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
por: You, Hong, et al.
Publicado: (2023) -
TRAF1 Gene Polymorphism Correlates with the Titre of Gp210 Antibody in Patients with Primary Biliary Cirrhosis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2012)